Back to
Vontobel Holding Ltd.
BBIO
Showing 6 of 13 quarters
Position history for
Vontobel Holding Ltd.'s holdings in BridgeBio Pharma, Inc.
Yes. Vontobel Holding holds 35,124 shares of BBIO (BridgeBio Pharma), worth $2.3M, as of its Q3 2026 13F filing. It reduced the position by 239 shares (-0.7%) from Q2 2026. Vontobel Holding has held BBIO since Q2 2025, across 6 quarterly 13F filings.
Current Value
$2.3M
Current Shares
35,124
Total Value Change
+$1.9M
Total Shares Change
+25,294
Quarter-by-Quarter History